𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis

✍ Scribed by Yasuyuki Miyakura; Kokichi Sugano; Fumio Konishi; Noriko Fukayama; Seiji Igarashi; Kenjiro Kotake; Takashi Matsui; Yasuo Koyama; Masato Maekawa; Hideo Nagai


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
438 KB
Volume
36
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Methylation of the MLH1 promoter region has been suggested to be a principal mechanism of gene inactivation in sporadic microsatellite instability (MSI)–positive colorectal carcinoma. Recently, we have shown a novel methylation profile of the MLH1 promoter region (i.e., full, partial, and no methylation), among which full methylation was strongly associated with MSI. In this study, to confirm whether methylation requires the involvement of both alleles, we studied the MLH1 promoter region concerning the methylation profile and allelic loss. Furthermore, we studied correlations of methylation profiles with genetic alternations such as loss of heterozygosity (LOH) of the TP53 locus and KRAS mutation. Eighty‐eight tumors were classified as full (n = 14), partial (n = 26), and no methylation (n = 48). Full methylation was observed in 78% (14/18) of high‐frequency MSI, in which all CpG sites in the promoter region were methylated. Full methylation differed significantly from partial methylation regarding absence of TP53 LOH (0/12) and KRAS mutation (0/14). In cases with full methylation, we could show biallelic methylation by use of a single‐base nucleotide polymorphism in the promoter. However, this did not accompany LOH of the MLH1 locus. In contrast, there were no significant differences in molecular features between partial and no methylation, except for low frequencies of LOH of the MLH1 locus (P = 0.02). In conclusion, biallelic extensive methylation of the MLH1 promoter region plays a significant role in gene inactivation and is independent of KRAS mutation and TP53 LOH. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Methylation pattern of different regions
✍ Mirco Menigatti; Carmela Di Gregorio; Francesca Borghi; Elisa Sala; Alessandra S 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract Nonrandom, widespread promoter methylation of tumor suppressor genes is a common mechanism of gene inactivation during tumorigenesis. We examined the methylation status of two distinct regions of the __MLH1__ promoter (proximal and distal to the transcription start site) and the __MLH1_

A specific CpG methylation pattern of th
✍ Klaus K.-F. Herfarth; Thomas P. Brent; Rebecca P. Danam; Joanna S. Remack; Ira J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The enzyme O 6 -methylguanine-DNA methyltransferase (MGMT) protects cells from the cytotoxic and mutagenic effects of alkylating agents. Approximately 20% of tumor cell lines lack MGMT activity and are highly sensitive to alkylating agents. In established cancer cell lines, MGMT expression appears t

Poorly differentiated adenocarcinoma and
✍ Takamitsu Kanazawa; Toshiaki Watanabe; Shinsuke Kazama; Toshihiro Tada; Shinichi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB

## Abstract Previous studies have reported that poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum (Por & Muc) show a low incidence and poor prognosis. However, genetic alterations and tumourigenesis of Por & Muc remain unclear. In our study, we analyzed the genetic